Method for Cell Line Development
    4.
    发明申请

    公开(公告)号:US20200002728A1

    公开(公告)日:2020-01-02

    申请号:US16490623

    申请日:2018-02-23

    Abstract: The present invention relates to an improved method for cell line development (CLD) which is generally applicable to production of any therapeutic protein that can be produced using mammalian Cell lines and in particular Chinese Hamster Ovary (CHO) cells. The method combines site-directed integration (SDI), expression construct components improving the post-transcriptional processing of the gene of interest (GOI) and the introduction of a onetime pre-CLD host cell line selection workflow to generate a production competent cell line that can then be used in multiple CLD efforts using SDI from that point on.

    Method for Cell Line Development
    8.
    发明申请

    公开(公告)号:US20180251790A1

    公开(公告)日:2018-09-06

    申请号:US15907470

    申请日:2018-02-28

    Abstract: The present invention relates to an improved method for cell line development which is generally applicable to production of any therapeutic protein that can be produced using mammalian Cell lines and in particular Chinese Hamster Ovary (CHO) cells.The method combines site directed integration (SDI), expression construct components improving the post-transcriptional processing of the gene of interest (GOI), novel design of the GOI genome target location and the introduction of a onetime pre-CLD host cell line selection workflow to generate a production competent cell line that can then be used in multiple CLD efforts from that point on.

    Method for cell line development
    10.
    发明授权

    公开(公告)号:US11802297B2

    公开(公告)日:2023-10-31

    申请号:US16490623

    申请日:2018-02-23

    CPC classification number: C12N15/907 C07K16/00 C12P21/00 C12N2510/02

    Abstract: The present invention relates to an improved method for cell line development (CLD) which is generally applicable to production of any therapeutic protein that can be produced using mammalian Cell lines and in particular Chinese Hamster Ovary (CHO) cells. The method combines site-directed integration (SDI), expression construct components improving the post-transcriptional processing of the gene of interest (GOI) and the introduction of a onetime pre-CLD host cell line selection workflow to generate a production competent cell line that can then be used in multiple CLD efforts using SDI from that point on.

Patent Agency Ranking